Jaroslaw Maciejewski, MD, Hematology, Cleveland, OH, Cleveland Clinic

JaroslawPMaciejewskiMD

Hematology Cleveland, OH

Professor of Medicine, Case West Res University

Dr. Maciejewski is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Maciejewski's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFELLOWSHIP
  • University of Nevada Reno School of Medicine
    University of Nevada Reno School of MedicineRESIDENCY
  • Humboldt University of Berlin- Charite Faculty of Medicine
    Humboldt University of Berlin- Charite Faculty of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2001 - 2020
  • DC State Medical License
    DC State Medical License 2000 - 2002
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Mutational Type and Configuration of an Individual Gene May Differentially Impact the Clinical and Phenotypic Features
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Eltrombopag Creates a Transient Chemical Phenocopy of TET2 Loss of Function That Contributes to Hematopoietic Precursor ExpansionClinically Relevant Abstract
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)
    Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Press Mentions

  • New Pediatric Bone Marrow Failure Clinic Focuses on Treatment, Prevention, Early Detection
    New Pediatric Bone Marrow Failure Clinic Focuses on Treatment, Prevention, Early DetectionApril 25, 2019
  • Three Targeted Agents in Development for Molecular Subtypes of Leukemia
    Three Targeted Agents in Development for Molecular Subtypes of LeukemiaFebruary 21, 2019
  • Chipping Away at the Mystery of Clonal Hematopoiesis of Indeterminate Potential (CHIP)
    Chipping Away at the Mystery of Clonal Hematopoiesis of Indeterminate Potential (CHIP)February 06, 2019
  • Join now to see all

Grant Support

  • Molecular Pathogenesis Of MDS And CMMLNational Heart, Lung, And Blood Institute2010–2012
  • Training/Research Center-Bone Marrow Failure SyndromesNational Heart, Lung, And Blood Institute2010–2011
  • Viral Pathogenesis Of Idiopathic Bone Marrow Failure And Immune CytopeniasNational Institute Of Allergy And Infectious Diseases2009–2011
  • Translational Hematology And Oncology Research Laboratory Expansion ProjectNational Center For Research Resources2010
  • Training/Research Center--Bone Marrow Failure SyndromesNational Heart, Lung, And Blood Institute2005–2009
  • TCR Diagnostics In LGL Leukemia And Immune CytopeniasNational Cancer Institute2005–2009
  • Predisposition To Chromosomal Alterations In MDSNational Heart, Lung, And Blood Institute2005–2008
  • Bone Marrow Failure Clinical Research CenterNational Center For Research Resources2004–2008
  • Molecular T Cell Repertoire In Aplastic AnemiaNational Heart, Lung, And Blood Institute2004–2007
  • Bone Marrow Failure Scientific SymposiumNational Heart, Lung, And Blood Institute2004
  • Bone Marrow Failure Clinical Research CenterNational Center For Research Resources2003

Hospital Affiliations